As expected, Denning et al. [49] found that down-regulation of Rab23 is seen in three malignant cohorts: follicular thyroid carcinoma, papillary thyroid carcinoma, and follicular variant of papillary thyroid carcinoma when compared with the benign follicular adenoma. Here, RAB23 is linked to differentiated thyroid carcinoma.